Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Revenue (2016 - 2025)

Historic Revenue for Rocket Pharmaceuticals (RCKT) over the last 1 years, with Q4 2016 value amounting to $525000.0.

  • Rocket Pharmaceuticals' Revenue changed N/A to $525000.0 in Q4 2016 from the same period last year, while for Sep 2017 it was $525000.0, marking a year-over-year change of. This contributed to the annual value of -$1.2 million for FY2015, which is 2551.02% down from last year.
  • According to the latest figures from Q4 2016, Rocket Pharmaceuticals' Revenue is $525000.0.
  • Rocket Pharmaceuticals' 5-year Revenue high stood at $525000.0 for Q4 2016, and its period low was -$525000.0 during Q3 2016.